Intervention not reported
- Conservative interventions for preventing clinically detectable upper‐limb lymphoedema in patients who are at risk of… 2015 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 183 participantsLow
Haloperidol showed no clear difference in clinically important response to treatment (short term) compared with first‐generation antipsychotics (low certainty).
Haloperidol showed no clear difference in leaving the study early due to any reason as a measure of overall… compared with first‐generation antipsychotics (low certainty).
It is very uncertain whether haloperidol changes leaving the study early due to inefficacy of treatment as a measure… compared with first‐generation antipsychotics (very low certainty).
It is very uncertain whether haloperidol changes leaving the study early due to adverse events as a measure of… compared with first‐generation antipsychotics (very low certainty).
Haloperidol showed no clear difference in adverse effects: number of participants with at least one adverse… compared with first‐generation antipsychotics (low certainty).
It is very uncertain whether haloperidol changes adverse effects: extrapyramidal side effects: number of participants… compared with first‐generation antipsychotics (very low certainty).
Tacrolimus 0.1% probably leads to higher physician's assessment of global response of improvement, clear or… compared with corticosteroids (moderate certainty).
It is very uncertain whether exercise therapy changes pain during activity (short‐term) Scale (0 to 10; higher scores mean… compared with a control strategy (no treatment, placebo or waiting list controls) (very low certainty).
It is very uncertain whether supervised exercises changes functional ability (short‐term) AKPS (0 to 100; higher scores mean… compared with home exercises (very low certainty).
It is very uncertain whether closed kinetic chain exercises changes pain during activity (short‐term) VAS (0 to 10; higher scores mean… compared with open kinetic chain exercises (very low certainty).
It is very uncertain whether closed kinetic chain exercises changes usual pain (short‐term) VAS (0 to 10; higher scores mean worse pain) compared with open kinetic chain exercises (very low certainty).
It is very uncertain whether closed kinetic chain exercises changes functional ability (short‐term) AKPS (0 to 100; higher scores mean… compared with open kinetic chain exercises (very low certainty).
It is very uncertain whether exercise therapy changes usual pain (short‐term) Scale (0 to 10; higher scores mean worse pain) compared with a control strategy (no treatment, placebo or waiting list controls) (very low certainty).
It is very uncertain whether target of exercise: hip + knee changes pain during activity (short‐term) Scale (0 to 10; higher scores mean… compared with knee exercises (very low certainty).
It is very uncertain whether target of exercise: hip + knee changes usual pain (short‐term) VAS (0 to 10; higher scores mean worse pain) compared with knee exercises (very low certainty).
It is very uncertain whether target of exercise: hip + knee changes functional ability (short‐term) Scale (0 to 100; higher scores mean… compared with knee exercises (very low certainty).
It is very uncertain whether target of exercise: hip changes pain during activity (short‐term) VAS (0 to 10; higher scores mean… compared with knee exercises (very low certainty).